Hemab Therapeutics
biotechnology company developing prophylactic therapeutics for bleeding and thrombotic disorders
Copenhagen, Denmarkhemab.com ↗
Total raised
€127M
€126,734,027
Funding rounds
1
Investors
9
distinct backers
Active since
2023-02
latest 2023-02
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood35
base rate 48% for Series B
- ▼ Overdue vs cohort gap
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-02-21 | Series B | €127M | Access Biotechnology,Avoro Ventures,Deep Track Capital,HealthCap,Invus,Maj Invest Equity+3 more | View deal → |
Investors
9Related news
- Hemab Therapeutics Raises $135M in Series B Financingfinsmes.com · 2023-02
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Oura Health€779MFinland · Healthtech
- Doctolib€734MFrance · E-commerce